Fig. 7
From: Active targeting schemes for nano-drug delivery systems in osteosarcoma therapeutics
Glycan binding proteins-related active targeting scheme design of nano-drug delivery systems. a The synthetic process of Man-SiO2@LDH nanocomposite. Copyright 2017, Nanomedicine: Nanotechnology, Biology and Medicine. b Schematic illustration of Fru–MnP nanocomposites prepared from fructose-1,6-diphosphate (FDP) and MnCl2·4H2O for the catalytic therapy of osteosarcoma. Copyright 2022, Nanoscale. c Schematic illustration for preparation, intravenous injection, in vivo circulation, selective accumulation in tumor tissue, and pH-triggered intracellular drug release of CDDPHANG/DOX. Copyright 2018, Advanced Science. d Schematic diagram of the construction of HA-PEG-nHA-ZOL nanoparticles. Copyright 2022, Frontiers in Bioengineering and Biotechnology